Metropolitan Life Insurance Company (MetLife)’s Adamas Pharmaceuticals, Inc. ADMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-7,606
| Closed | -$152K | – | 2590 |
|
|
2018
Q3 | $152K | Hold |
7,606
| – | – | ﹤0.01% | 2196 |
|
|
2018
Q2 | $196K | Buy |
7,606
+2,293
| +43% | +$59.2K | ﹤0.01% | 1955 |
|
|
2018
Q1 | $127K | Hold |
5,313
| – | – | ﹤0.01% | 2170 |
|
|
2017
Q4 | $180K | Sell |
5,313
-5,115
| -49% | -$173K | ﹤0.01% | 1975 |
|
|
2017
Q3 | $221K | Hold |
10,428
| – | – | ﹤0.01% | 2218 |
|
|
2017
Q2 | $182K | Hold |
10,428
| – | – | ﹤0.01% | 2395 |
|
|
2017
Q1 | $182K | Hold |
10,428
| – | – | ﹤0.01% | 2328 |
|
|
2016
Q4 | $176K | Hold |
10,428
| – | – | ﹤0.01% | 2430 |
|
|
2016
Q3 | $171K | Hold |
10,428
| – | – | ﹤0.01% | 2433 |
|
|
2016
Q2 | $158K | Buy |
+10,428
| New | +$158K | ﹤0.01% | 2491 |
|
|
2015
Q4 | – | Sell |
-7,926
| Closed | -$133K | – | 2650 |
|
|
2015
Q3 | $133K | Hold |
7,926
| – | – | ﹤0.01% | 2527 |
|
|
2015
Q2 | $208K | Buy |
+7,926
| New | +$208K | ﹤0.01% | 2376 |
|